OncoDrug Panels, Brand Mylab

Pharmacogenomics individual variability in drug efficacy and drug protection is a major challenge in current clinical practice, And drug regulation, Drug development. Pharmacogenomics and personalised drug therapy, Both are increasingly influencing cancer treatment, Recently. Personalized therapy for cancer is one in which the chemotherapy regimen is chosen based partly on genetic tests of the patient. In presence of, Majority cases single nucleotide polymorphisms snps in the order of the genes encoding proteins that take part in metabolism of anti, Cancer drug are attributed to inter, Individual variability in drug response. Drugdecide panels details drugdecide series provides allelic discrimination PCR analysis conducted in real timewhich uses a set of primer with two fluorogenic probes basedchemistry that discriminates mutant allele from wild type within one tube. The kit features the complete set of reagents starting with a sample and continuing to snp detection. An integration of robust reagents for dna extraction from clinicalsamples and validated primers, Hydrolysis probes in addition to hotstart taq polymerase for snp detection ensures that kit leads tohighly specific and sensitive results in short time. Kit features highly sensitive snp screening kitsmultiplex analysis with no requirements for optimization, Detects wild and mutant type in one goStreamlined processes with pre-prepared solutions and top-notch quality controlsimple arrangement for the reaction and data interpretationincludes all necessary reagents needed for sample analysis outcome evaluation without extra reagents needed. Results aligned with wild and mutant controls This package offers a low risk of contamination, Eliminating the requirement for post-PCR steps product handlinghigh, Throughput and quick outcomes within under 80 minutes after pcr startkit contents reagents for isolating dna from blood samplesreagents required snp screening on rtpcrvalidated reaction controls